Scleroderma/Systemic Sclerosis
Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study
22
The HLA DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma)
7
Cutaneous antigen stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma)
8
Systemic Sclerosis Sine Scleroderma With Pulmonary Arterial Hypertension in a 3-Year-Old Girl
7
Pressure and pain In Systemic sclerosis/Scleroderma an evaluation of a simple intervention (PISCES): randomised controlled trial protocol
8
Pressure and pain In Systemic sclerosis/Scleroderma - an evaluation of a simple intervention (PISCES): randomised controlled trial protocol
8
Primary myocardial disease in scleroderma – a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group
15
Systemic sclerosis sine scleroderma
6
Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis
10
Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group
10
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
6
Atypical clinical presentation of a subset of patients with anti RNA polymerase III non scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining
7
Systemic sclerosis medications and risk of scleroderma renal crisis
7
Primary myocardial disease in scleroderma – a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group
33
Vascular involvement in systemic sclerosis (scleroderma)
21
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).
12
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
14
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
9
Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma
9
A Study of Cardio Pulmonary Manifestations in Systemic Sclerosis
110